Nanobiotix S.A. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Nanobiotix S.A. (NNBXF) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of -EUR 4.34 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2026-03-31
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | -4.34M EUR 20-F · filed 2026-03-31 |
| 2024-12-31 | -2.23M EUR 20-F · filed 2026-03-31 |
| 2023-12-31 | -2.88M EUR 20-F · filed 2026-03-31 |
| 2022-12-31 | -1.17M EUR 20-F · filed 2025-04-02 |
| 2021-12-31 | -109.00K EUR 20-F · filed 2024-04-24 |
| 2020-12-31 | -1.70M EUR 20-F · filed 2023-04-24 |
| 2019-12-31 | -176.00K EUR 20-F · filed 2022-04-08 |